SGH
Sivik Global Healthcare Portfolio holdings
AUM
$224M
This Quarter Return
+1.72%
1 Year Return
+5.3%
3 Year Return
+45.33%
5 Year Return
+103.79%
10 Year Return
+430.94%
AUM
$252M
AUM Growth
+$252M
(-6.9%)
Cap. Flow
-$23.7M
Cap. Flow
% of AUM
-9.38%
Top 10 Holdings %
Top 10 Hldgs %
29.07%
Holding
74
New
14
Increased
11
Reduced
28
Closed
13
Top Buys
| 1 |
Becton Dickinson
BDX
|
$8.19M |
| 2 |
UnitedHealth
UNH
|
$7.32M |
| 3 |
Pfizer
PFE
|
$6.5M |
| 4 |
Tenet Healthcare
THC
|
$3.51M |
| 5 |
Neurocrine Biosciences
NBIX
|
$3.38M |
Top Sells
| 1 |
Novo Nordisk
NVO
|
$7.06M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$6.08M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$4.28M |
| 4 |
Viatris
VTRS
|
$4.25M |
| 5 |
Biogen
BIIB
|
$3.55M |
Sector Composition
| 1 | Healthcare | 95.16% |
| 2 | Energy | 1.18% |
| 3 | Utilities | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Sanofi
SNY
$121B
| $4.33M | 1.05% |
100,000
-30,000
| -23% | -$1.3M |
|
|
GWPH
27
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| $4.31M | 1.04% |
25,000
-5,000
| -17% | -$862K |
|
28
Sarepta Therapeutics
SRPT
$1.78B
| $4.18M | 1.01% |
27,500
+12,500
| +83% | +$1.9M |
|
29
AstraZeneca
AZN
$248B
| $4.13M | 1% |
100,000
-50,000
| -33% | -$2.06M |
|
30
Intuitive Surgical
ISRG
$170B
| $3.93M | 0.95% |
7,500
-2,500
| -25% | -$1.31M |
|
31
Incyte
INCY
$16.5B
| $3.82M | 0.92% |
45,000
-15,000
| -25% | -$1.27M |
|
32
Bausch Health
BHC
$2.74B
| $3.53M | 0.85% |
140,000
-60,000
| -30% | -$1.51M |
|
|
33
Tenet Healthcare
THC
$16.3B
| $3.51M | 0.85% |
+170,000
| New | +$3.51M |
|
|
34
Neurocrine Biosciences
NBIX
$13.8B
| $3.38M | 0.82% |
+40,000
| New | +$3.38M |
|
35
Agilent Technologies
A
$35.7B
| $3.36M | 0.81% |
45,000
| – | – |
|
36
Dentsply Sirona
XRAY
$2.85B
| $3.21M | 0.78% |
55,000
| – | – |
|
37
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $3.2M | 0.77% |
145,000
-80,000
| -36% | -$1.77M |
|
|
SAGE
38
DELISTED
Sage Therapeutics
SAGE
| $3.2M | 0.77% |
17,500
+7,500
| +75% | +$1.37M |
|
|
BLUE
39
DELISTED
bluebird bio
BLUE
| $3.18M | 0.77% |
25,000
+7,295
| +41% | +$928K |
|
40
Centene
CNC
$14.3B
| $3.16M | 0.76% |
60,300
-19,700
| -25% | -$1.03M |
|
41
Stryker
SYK
$150B
| $3.08M | 0.75% |
15,000
-15,000
| -50% | -$3.08M |
|
42
Quest Diagnostics
DGX
$20.3B
| $3.05M | 0.74% |
+30,000
| New | +$3.05M |
|
43
BioMarin Pharmaceuticals
BMRN
$11.2B
| $3M | 0.72% |
35,000
-10,000
| -22% | -$857K |
|
|
LHCG
44
DELISTED
LHC Group LLC
LHCG
| $2.99M | 0.72% |
25,000
-10,000
| -29% | -$1.2M |
|
45
Medtronic
MDT
$119B
| $2.92M | 0.71% |
+30,000
| New | +$2.92M |
|
|
BPMC
46
DELISTED
Blueprint Medicines
BPMC
| $2.83M | 0.68% |
30,000
+5,000
| +20% | +$472K |
|
|
AMED
47
DELISTED
Amedisys
AMED
| $2.43M | 0.59% |
20,000
| – | – |
|
|
SGEN
48
DELISTED
Seagen Inc. Common Stock
SGEN
| $2.42M | 0.59% |
35,000
+25,000
| +250% | +$1.73M |
|
49
IQVIA
IQV
$32.4B
| $2.41M | 0.58% |
+15,000
| New | +$2.41M |
|
50
Exact Sciences
EXAS
$8.98B
| $2.36M | 0.57% |
+20,000
| New | +$2.36M |
|